We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Absinthe's Effects were Due to High Alcohol Content

By Labmedica staff writers
Posted on 07 May 2008
Absinthe--the exotic green aperitif--was believed to possess mind-altering effects and toxic side effects when consumed to excess. More...
A team of scientists from Europe and the United States has concluded that the culprit was the high alcohol content, rather than thujone, the compound widely believed responsible for absinthe's effects.

Although consumed diluted with water, absinthe contained about 70% alcohol, giving it a "140-proof wallop.” In late 19th-century, Paris bohemian artists and writers believed it expanded consciousness with psychedelic effects and called it "the Green Fairy” and "the Green Muse.” The drink's popularity spread through Europe and to the United States. However, illness and violent episodes among drinkers gave absinthe the reputation as a dangerous drug, and it was banned in Europe and elsewhere.

In a new study, Dirk W. Lachenmeier, Ph.D., from the Chemisches und Veterinäruntersuchungsamt (CVUA; Karlsruhe, Germany) and colleagues analyzed 13 samples of pre-ban absinthe from sealed bottles--"the first time that such a wide ranging analysis of absinthe from the pre-ban era has been attempted.” The study appeared online in the April 18, 2008 edition of the American Chemical Society's bi-weekly Journal of Agricultural and Food Chemistry.

The comprehensive chemical analysis included thujone, widely regarded as the "active” ingredient in absinthe. "It is certainly at the root of absinthe's reputation as being more drug than drink,” according to Dr. Lachenmeier. Thujone was blamed for "absinthe madness” and "absinthism,” a collection of symptoms including hallucinations, facial contractions, numbness, and dementia.

The researchers explained that scientists know very little about the composition of the original absinthe produced in France before that country banned the drink in 1915. Only a single study had previously analyzed one sample of preban absinthe.

However, the study by Dr. Lachenmeier found relatively small concentrations of thujone, amounts less than previously estimated and not sufficient to explain absinthism. Thujone levels in preban absinthe actually were about the same as those in modern absinthe, produced since 1988, when the European Union (EU) lifted its ban on absinthe production. Extensive laboratory tests found no other compound that could explain absinthe's effects.

"All things considered, nothing besides ethanol was found in the absinthes that was able to explain the syndrome of absinthism,” according to Dr. Lachenmeier. He added that scientific data could not explain preban absinthe's reputation as a psychedelic substance. Recent historic research on absinthism concluded that the condition probably was alcoholism.


Related Links:
Chemisches und Veterinäruntersuchungsamt

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Electrolyte Analyzer
BKE-B
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.